Literature DB >> 32985160

[Early differential diagnosis between COVID-19 and mycoplasma pneumonia with chest CT scan].

Xianluo Huo1, Xiaohua Xue2, Shuhui Yuan3, Dianchun Zhang4, Qing'e Gao5, Tao Gong6.   

Abstract

OBJECTIVE: To early differentiate between coronavirus disease 2019 (COVID-19) and adult mycoplasma pneumonia with chest CT scan.
METHODS: Twenty-six patients with COVID-19 and 21 patients with adult mycoplasma pneumonia confirmed with RT-PCR test were enrolled from Zibo First Hospital and Lanshan People's Hospital during December 1st 2019 and March 14th 2020. The early chest CT manifestations were analyzed and compared between the two groups.
RESULTS: The interstitial changes with ground glass density shadow (GGO) were similar in two groups during first chest CT examination (P>0.05). There were more lung lobes involved on the first chest CT in COVID-19 patients, which were mostly distributed in the dorsal outer zone (23/26, 88.5%), and nearly half of them (12/26, 46.2%) were accompanied by crazy-paving sign; while the lesions in adult mycoplasma pneumonia patients were mostly distributed along the bronchi, and the bronchial wall was thickened (19/21, 90.5%), accompanied with tree buds / fog signs (19/21, 90.5%). The above CT signs were significantly different between the two kinds of pneumonia (all P<0.01). COVID-19 had a longer course compared with mycoplasma pneumonia, the disease peaks of COVID-19 patients was on day (10.5±3.8), while the disease on CT was almost absorbed on day (7.9±2.2) in adult mycoplasma pneumonia. The length of hospital stay in COVID-19 patients was significantly longer than that of mycoplasma pneumonia patients [(19.5±4.3) d vs (7.9±2.2) d, P<0.01].
CONCLUSIONS: The lesions of adult mycoplasma pneumonia are mostly distributed along the bronchi with tree buds/fog signs, while the lesions of COVID-19 are mainly distributed in the dorsal outer zone accompanied by crazy-paving sign, which can early distinguish two diseases.

Entities:  

Keywords:  Computed tomography; Coronavirus disease 2019; Crazy-paving sign; Mycoplasma pneumoniae; Tree-bud sign

Mesh:

Year:  2020        PMID: 32985160      PMCID: PMC8800730          DOI: 10.3785/j.issn.1008-9292.2020.07.04

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  18 in total

1.  Mycoplasma pneumoniae pneumonia: radiographic and high-resolution CT features in 28 patients.

Authors:  P Reittner; N L Müller; L Heyneman; T Johkoh; J S Park; K S Lee; O Honda; N Tomiyama
Journal:  AJR Am J Roentgenol       Date:  2000-01       Impact factor: 3.959

2.  Timely Diagnosis and Treatment Shortens the Time to Resolution of Coronavirus Disease (COVID-19) Pneumonia and Lowers the Highest and Last CT Scores From Sequential Chest CT.

Authors:  Guoquan Huang; Tao Gong; Guangbin Wang; Jianwen Wang; Xinfu Guo; Erpeng Cai; Shirong Li; Xiaohu Li; Yongqiang Yu; Liangjie Lin
Journal:  AJR Am J Roentgenol       Date:  2020-03-30       Impact factor: 3.959

3.  Gross examination report of a COVID-19 death autopsy.

Authors:  Q Liu; R S Wang; G Q Qu; Y Y Wang; P Liu; Y Z Zhu; G Fei; L Ren; Y W Zhou; L Liu
Journal:  Fa Yi Xue Za Zhi       Date:  2020-02-25

Review 4.  Correlation between Radiological and Pathological Findings in Patients with Mycoplasma pneumoniae Pneumonia.

Authors:  Hiroshi Tanaka
Journal:  Front Microbiol       Date:  2016-05-11       Impact factor: 5.640

5.  Accuracy of lung ultrasonography in the hands of non-imaging specialists to diagnose and assess the severity of community-acquired pneumonia in adults: a systematic review.

Authors:  Julie Jepsen Strøm; Pia Sperling Haugen; Malene Plejdrup Hansen; Ole Graumann; Martin Bach B Jensen; Camilla Aakjær Andersen
Journal:  BMJ Open       Date:  2020-06-17       Impact factor: 2.692

6.  Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR.

Authors:  Yicheng Fang; Huangqi Zhang; Jicheng Xie; Minjie Lin; Lingjun Ying; Peipei Pang; Wenbin Ji
Journal:  Radiology       Date:  2020-02-19       Impact factor: 11.105

7.  Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.

Authors:  Xi Xu; Chengcheng Yu; Jing Qu; Lieguang Zhang; Songfeng Jiang; Deyang Huang; Bihua Chen; Zhiping Zhang; Wanhua Guan; Zhoukun Ling; Rui Jiang; Tianli Hu; Yan Ding; Lin Lin; Qingxin Gan; Liangping Luo; Xiaoping Tang; Jinxin Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-28       Impact factor: 9.236

8.  Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.

Authors:  Gian Paolo Rossi; Viola Sanga; Matthias Barton
Journal:  Elife       Date:  2020-04-06       Impact factor: 8.140

9.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome.

Authors:  Zhe Xu; Lei Shi; Yijin Wang; Jiyuan Zhang; Lei Huang; Chao Zhang; Shuhong Liu; Peng Zhao; Hongxia Liu; Li Zhu; Yanhong Tai; Changqing Bai; Tingting Gao; Jinwen Song; Peng Xia; Jinghui Dong; Jingmin Zhao; Fu-Sheng Wang
Journal:  Lancet Respir Med       Date:  2020-02-18       Impact factor: 30.700

10.  Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer.

Authors:  Sufang Tian; Weidong Hu; Li Niu; Huan Liu; Haibo Xu; Shu-Yuan Xiao
Journal:  J Thorac Oncol       Date:  2020-02-28       Impact factor: 15.609

View more
  1 in total

1.  Application of CT images based on the optimal atlas segmentation algorithm in the clinical diagnosis of Mycoplasma Pneumoniae Pneumonia in Children.

Authors:  Xilin Fu; Ningfei Yang; Jianwei Ji
Journal:  Pak J Med Sci       Date:  2021       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.